124 related articles for article (PubMed ID: 11468553)
1. Sirolimus-associated eyelid edema in kidney transplant recipients.
Mohaupt MG; Vogt B; Frey FJ
Transplantation; 2001 Jul; 72(1):162-4. PubMed ID: 11468553
[TBL] [Abstract][Full Text] [Related]
2. [Edema of the eyelids caused by sirolimus in renal transplant recipients].
Schmutz JL; Barbaud A; Trechot P
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):83. PubMed ID: 12605170
[No Abstract] [Full Text] [Related]
3. Immunosuppressant-Related Lower Eyelid Edema in Transplant Patients.
Logan SA; Thyparampil PJ; Yen MT
Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S58-S60. PubMed ID: 26730861
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.
Kahan BD; Podbielski J; Napoli KL; Katz SM; Meier-Kriesche HU; Van Buren CT
Transplantation; 1998 Oct; 66(8):1040-6. PubMed ID: 9808489
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients.
Hakeam HA; Al-Jedai AH; Raza SM; Hamawi K
Ann Transplant; 2008; 13(2):46-53. PubMed ID: 18566560
[TBL] [Abstract][Full Text] [Related]
6. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
[TBL] [Abstract][Full Text] [Related]
7. Conversion to sirolimus in a population of kidney and kidney-pancreas transplant recipients.
Almeida M; Martins LS; Dias L; Figueiredo MJ; Henriques AC; Sarmento AM; Cabrita A
Transplant Proc; 2005; 37(6):2777-80. PubMed ID: 16182808
[TBL] [Abstract][Full Text] [Related]
8. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA
Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603
[TBL] [Abstract][Full Text] [Related]
9. [Lymphocele and kidney transplantation].
Langer R; Tóth A; Máthé Z; Remport A; Járay J; Kahan BD
Orv Hetil; 2007 Aug; 148(31):1475-80. PubMed ID: 17656338
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.
Chatel MA; Larkin DF
Am J Ophthalmol; 2010 Aug; 150(2):179-84. PubMed ID: 20570235
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
Kreis H; Cisterne JM; Land W; Wramner L; Squifflet JP; Abramowicz D; Campistol JM; Morales JM; Grinyo JM; Mourad G; Berthoux FC; Brattström C; Lebranchu Y; Vialtel P
Transplantation; 2000 Apr; 69(7):1252-60. PubMed ID: 10798738
[TBL] [Abstract][Full Text] [Related]
13. Causes of sirolimus discontinuation in 97 liver transplant recipients.
Panaro F; Piardi T; Gheza F; Ellero B; Audet M; Cag M; Cinqualbre J; Wolf P
Transplant Proc; 2011 May; 43(4):1128-31. PubMed ID: 21620069
[TBL] [Abstract][Full Text] [Related]
14. Subclinical rejection and sirolimus associated edema in renal allograft recipients.
Rico J; Cruzado JM; Bestard O; Duarte V; Rama I; Gomà M; Torras J; Grinyó JM
Transpl Int; 2007 Jul; 20(7):636-9. PubMed ID: 17442067
[No Abstract] [Full Text] [Related]
15. A Case of Everolimus-Induced Eyelid Edema.
Schear MJ; Rodgers R
Ophthalmic Plast Reconstr Surg; 2018; 34(1):e21-e22. PubMed ID: 28746253
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
Kahan BD
Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
18. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
Boratynska M; Banasik M; Patrzalek D; Klinger M
Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
[TBL] [Abstract][Full Text] [Related]
19. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients.
Kahan BD; Yakupoglu YK; Schoenberg L; Knight RJ; Katz SM; Lai D; Van Buren CT
Transplantation; 2005 Sep; 80(6):749-58. PubMed ID: 16210961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
